TITLE

Advances in Pancreatic Neuroendocrine Tumor Treatment

AUTHOR(S)
Castellano, Daniel; Grande, Enrique; Barriuso, Jorge
PUB. DATE
May 2011
SOURCE
New England Journal of Medicine;5/12/2011, Vol. 364 Issue 19, p1871
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors," by E. Raymond et al, in the February 10, 2011 issue.
ACCESSION #
60596264

 

Related Articles

  • Advances in Pancreatic Neuroendocrine Tumor Treatment. Mir, Olivier; Coriat, Romain; Goldwasser, Fran�ois // New England Journal of Medicine;5/12/2011, Vol. 364 Issue 19, p1871 

    A letter to the editor is presented in response to the article "Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors," by E. Raymond et al, in the February 10, 2011 issue.

  • Advances in Pancreatic Neuroendocrine Tumor Treatment. Berruti, Alfredo; Pia, Anna; Terzolo, Massimo // New England Journal of Medicine;5/12/2011, Vol. 364 Issue 19, p1871 

    A letter to the editor is presented in response to the article "Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors," by E. Raymond et al, in the February 10, 2011 issue.

  • Advances in Pancreatic Neuroendocrine Tumor Treatment. van der Veldt, Astrid A.M.; Kleijn, Sebastiaan A. // New England Journal of Medicine;5/12/2011, Vol. 364 Issue 19, p1871 

    A letter to the editor is presented in response to an articles "Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors," by E. Raymond et al and "Everolimus for Advanced Pancreatic Neuroendocrine Tumors," by J. C. Yao et al, in the February 10, 2011 issue.

  • Advances in Pancreatic Neuroendocrine Tumor Treatment. Faivre, Sandrine; James, Lee P.; Raymond, Eric // New England Journal of Medicine;5/12/2011, Vol. 364 Issue 19, p1871 

    A response by Eric Raymond et al to letters to the editor about their article "Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors" is presented.

  • Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail. Savolainen, Sauli; Konijnenberg, Mark; Bardiès, Manuel; Lassmann, Michael; Strigari, Lidia; Chiesa, Carlo; Chiti, Arturo; Reijonin, Vappu; Flux, Glenn // European Journal of Nuclear Medicine & Molecular Imaging;Mar2012, Vol. 39 Issue 3, p548 

    A letter to the editor is presented in response to the article "Clinical results of radionuclide therapy of neuroendocrine tumours with (90)Y-DOTATATE and tandem (90)Y/(177)Lu-DOTATATE: which is a better therapy option?" by J. Kunikowska, A. Hubalewska-Dydejczyk in the 2011 issue.

  • Hemodialysis no reason to withhold everolimus. Rooijen, J.; Vries, E. // Cancer Chemotherapy & Pharmacology;Jan2013, Vol. 71 Issue 1, p273 

    No abstract available.

  • Erratum to: Twins in spirit: DOTATATE and high-affinity DOTATATE. Brogsitter, Claudia; Schottelius, Margret; Zöphel, Klaus; Kotzerke, Jörg; Wester, Hans-Jürgen // European Journal of Nuclear Medicine & Molecular Imaging;Feb2014, Vol. 41 Issue 2, p402 

    A correction to the article "Twins in spirit: DOTATATE and high-affinity DOTATATE" that was published in the September 21, 2013 issue is presented.

  • Sunitinib.  // Reactions Weekly;10/6/2012, Issue 1422, p45 

    The article describes the case of a woman who developed perirenal hematoma following treatment with sunitinib for metastatic pancreatic neuroendocrine tumor.

  • DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy. Otte, A.; Jermann, E.; Behe, M.; Goetze, M.; Bucher, H. C.; Roser, H. W.; Heppeler, A.; Mueller-Brand, J.; Maecke, H. R. // European Journal of Nuclear Medicine;1997, Vol. 24 Issue 7, p792 

    This study presents the first successful use of a peptidic vector, DOTATOC, labelled with the �-emitting radioisotope yttrium-90, for the treatment of a patient with somatostatin receptor-positive abdominal metastases of a neuroendocrine carcinoma of unknown localization. Tumour response...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics